Sort   by:  
 Page size 
ProteomicsHuman LC-MS Data in HEK293T overexpressed LATS2
LC-MS data for Enzyme Activity-Independent NANS Stabilizes LATS2 to Drive Growth and Confer Resistance to Endocrine Therapy and CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
ORGANISM(S): Homo sapiens (Human) 
2025-12-14 | PXD065340 | Pride
Human lc-ms lats2 
ProteomicsHuman data-independent acquisition (DIA) quantitative proteomics data
raw data-independent acquisition (DIA) quantitative proteomics data for Enzyme Activity-Independent NANS Stabilizes LATS2 to Drive Growth and Confer Resistance to Endocrine Therapy and CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
ORGANISM(S): Homo sapiens (Human) 
2026-06-05 | PXD065351 | Pride
Human breast nans 
UnknownTOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression.
Not available
S-EPMC9980475 | biostudies-literature
UnknownC9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple-negative breast cancer.
Not available
S-EPMC10679971 | biostudies-literature
UnknownDestabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents.
Not available
S-EPMC10040724 | biostudies-literature
UnknownSF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1.
Not available
S-EPMC10990288 | biostudies-literature
UnknownProtein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer.
Not available
S-EPMC9896024 | biostudies-literature
UnknownSecernin-2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple-Negative Breast Cancer.
Not available
S-EPMC11905051 | biostudies-literature
UnknownBisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1.
Not available
S-EPMC12808305 | biostudies-literature
UnknownMYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast Cancer.
Not available
S-EPMC12442607 | biostudies-literature
Sort   by:  
 Page size